Suzie Seabroke

576 total citations
12 papers, 418 citations indexed

About

Suzie Seabroke is a scholar working on Epidemiology, Toxicology and Pharmacology. According to data from OpenAlex, Suzie Seabroke has authored 12 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Toxicology and 2 papers in Pharmacology. Recurrent topics in Suzie Seabroke's work include Pharmacovigilance and Adverse Drug Reactions (4 papers), Respiratory viral infections research (3 papers) and Pneumonia and Respiratory Infections (3 papers). Suzie Seabroke is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (4 papers), Respiratory viral infections research (3 papers) and Pneumonia and Respiratory Infections (3 papers). Suzie Seabroke collaborates with scholars based in United Kingdom, Spain and United States. Suzie Seabroke's co-authors include A Wisniewski, Gianmario Candore, Kristina Juhlin, Jim Slattery, Bharat Thakrar, Katrin Manlik, Katherine Donegan, G. Niklas Norén, Andreas Brueckner and Michael Kayser and has published in prestigious journals such as PLoS ONE, Vaccine and Drug Safety.

In The Last Decade

Suzie Seabroke

10 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzie Seabroke United Kingdom 8 216 91 82 67 53 12 418
Lionel Van Holle Belgium 11 215 1.0× 79 0.9× 73 0.9× 83 1.2× 42 0.8× 17 385
Ana Alvarez-Requejo Spain 8 247 1.1× 58 0.6× 32 0.4× 90 1.3× 51 1.0× 13 576
Hélène Théophile France 15 228 1.1× 79 0.9× 42 0.5× 171 2.6× 43 0.8× 28 602
Kristina Juhlin Sweden 12 391 1.8× 39 0.4× 150 1.8× 134 2.0× 64 1.2× 17 554
Alexandra Păcurariu Netherlands 12 184 0.9× 60 0.7× 37 0.5× 105 1.6× 43 0.8× 24 524
Cecilia Biriell Sweden 7 189 0.9× 31 0.3× 45 0.5× 84 1.3× 19 0.4× 10 423
Stephen A. Goldman United States 7 109 0.5× 27 0.3× 24 0.3× 45 0.7× 14 0.3× 20 407
Boris Kerzner United States 10 72 0.3× 201 2.2× 39 0.5× 56 0.8× 27 0.5× 11 878
Vaishali Patadia United States 9 347 1.6× 37 0.4× 116 1.4× 92 1.4× 41 0.8× 13 525
Tomas Bergvall Sweden 10 236 1.1× 21 0.2× 74 0.9× 68 1.0× 44 0.8× 12 356

Countries citing papers authored by Suzie Seabroke

Since Specialization
Citations

This map shows the geographic impact of Suzie Seabroke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzie Seabroke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzie Seabroke more than expected).

Fields of papers citing papers by Suzie Seabroke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzie Seabroke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzie Seabroke. The network helps show where Suzie Seabroke may publish in the future.

Co-authorship network of co-authors of Suzie Seabroke

This figure shows the co-authorship network connecting the top 25 collaborators of Suzie Seabroke. A scholar is included among the top collaborators of Suzie Seabroke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzie Seabroke. Suzie Seabroke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Seabroke, Suzie, Pimnara Peerawaranun, Estelle Méroc, et al.. (2024). Hospitalization cost estimates of respiratory syncytial virus and influenza infections in adults in Spain, 2016–2019. Vaccine. 46. 126683–126683.
2.
Seabroke, Suzie, et al.. (2024). Economic burden of children hospitalized with respiratory syncytial virus infection in Spain, 2016–2019. Vaccine. 43(Pt 2). 126512–126512. 3 indexed citations
3.
Law, Anica C., et al.. (2023). EE31 Economic Burden of Hospitalized Respiratory Syncytial Virus Infection Among Children in Spain, 2016–2019. Value in Health. 26(12). S55–S55. 2 indexed citations
4.
Seabroke, Suzie, Jenny Wong, Katherine Donegan, et al.. (2018). Safety of multicomponent meningococcal group B vaccine (4CMenB) in routine infant immunisation in the UK: a prospective surveillance study. The Lancet Child & Adolescent Health. 2(6). 395–403. 46 indexed citations
5.
Wisniewski, A, Andrew Bate, Cédric Bousquet, et al.. (2016). Good Signal Detection Practices: Evidence from IMI PROTECT. Drug Safety. 39(6). 469–490. 106 indexed citations
6.
Seabroke, Suzie, Gianmario Candore, Kristina Juhlin, et al.. (2016). Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous Databases. Drug Safety. 39(4). 355–364. 43 indexed citations
7.
Candore, Gianmario, Kristina Juhlin, Katrin Manlik, et al.. (2015). Comparison of Statistical Signal Detection Methods Within and Across Spontaneous Reporting Databases. Drug Safety. 38(6). 577–587. 106 indexed citations
8.
Seabroke, Suzie, Kristina Juhlin, Gianmario Candore, et al.. (2014). Impact of Subgroup Analyses and Adjustment by Stratification on Safety Signal Detection for Individual Case Reports. Pharmacoepidemiology and Drug Safety. 23. 416–416.
9.
Seabroke, Suzie, Lesley Wise, & Patrick Waller. (2013). Development of a Novel Regulatory Pharmacovigilance Prioritisation System: An Evaluation of Its Performance at the UK Medicines and Healthcare products Regulatory Agency. Drug Safety. 36(10). 1025–1032. 14 indexed citations
10.
Donegan, Katherine, et al.. (2013). Bivalent human papillomavirus vaccine and the risk of fatigue syndromes in girls in the UK. Vaccine. 31(43). 4961–4967. 51 indexed citations
11.
Stowe, Julia, et al.. (2011). Risk of convulsions in children after monovalent H1N1 (2009) and trivalent influenza vaccines: A database study. Vaccine. 29(51). 9467–9472. 20 indexed citations
12.
Gallagher, Arlene M., Liam Smeeth, Suzie Seabroke, Hubert G. M. Leufkens, & Tjeerd van Staa. (2011). Risk of Death and Cardiovascular Outcomes with Thiazolidinediones: A Study with the General Practice Research Database and Secondary Care Data. PLoS ONE. 6(12). e28157–e28157. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lionel Van Holle Breakdown of academic impact, for papers by Ana Alvarez-Requejo Breakdown of academic impact, for papers by Hélène Théophile Breakdown of academic impact, for papers by Kristina Juhlin Breakdown of academic impact, for papers by Alexandra Păcurariu Breakdown of academic impact, for papers by Cecilia Biriell Breakdown of academic impact, for papers by Stephen A. Goldman Breakdown of academic impact, for papers by Boris Kerzner Breakdown of academic impact, for papers by Vaishali Patadia Breakdown of academic impact, for papers by Tomas Bergvall
Rankless by CCL
2026